Xia Men Meng Peng Mao Yi You Xian Gong Si – Trademark Portfolio

Entity Type: 99

Xia Men Meng Peng Mao Yi You Xian Gong Si holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include A7MOUTH. The owner is based in FuJianShengLongHai Shi.

Xin Cuo Cun Hou Cuo 93 Hao

Long Jiao She Zu Xiang

FuJianShengLongHai Shi 363100 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

A7MOUTH
A7MOUTH
Registered 2024

Trademark Classifications

Xia Men Meng Peng Mao Yi You Xian Gong Si's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Xia Men Meng Peng Mao Yi You Xian Gong Si have?

Xia Men Meng Peng Mao Yi You Xian Gong Si has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xia Men Meng Peng Mao Yi You Xian Gong Si file in?

Xia Men Meng Peng Mao Yi You Xian Gong Si files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Xia Men Meng Peng Mao Yi You Xian Gong Si's most well-known trademarks?

Xia Men Meng Peng Mao Yi You Xian Gong Si's registered trademark portfolio includes well-known marks such as A7MOUTH. These are among 1 currently registered trademark in the portfolio.

What is Xia Men Meng Peng Mao Yi You Xian Gong Si's trademark registration success rate?

Xia Men Meng Peng Mao Yi You Xian Gong Si has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.